Related Experiment Video
Updated: Jan 7, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Arteriovenous Malformations (AVMs): Molecular Pathogenesis, Clinical Features, and Emerging Therapeutic Strategies
Nga Le1,2, Yan Li1, Gianni Walker1
1DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Arteriovenous malformations (AVMs) result from genetic and molecular factors, leading to high-risk vascular shunts. Advances in imaging and treatments like embolization and precision medicine improve patient outcomes and quality of life.
Area of Science:
- Vascular biology and medicine
- Genetics and molecular mechanisms of vascular disease
- Medical imaging and interventional radiology
Background:
- Arteriovenous malformations (AVMs) are direct artery-to-vein shunts lacking capillaries, posing risks of hemorrhage and organ damage.
- AVMs develop from a complex interplay of genetic susceptibility, somatic mutations, signaling pathway dysregulation, hemodynamic stress, and inflammation.
- Recent scientific synthesis highlights the multifaceted etiology of AVMs.
Purpose of the Study:
- To synthesize recent advances in understanding the pathogenesis of AVMs.
- To review current diagnostic and risk stratification imaging modalities.
- To outline contemporary and emerging management strategies, including interventional and precision medicine approaches.
Main Methods:
- Comprehensive review and synthesis of current literature on AVMs.
- Analysis of multimodal imaging techniques for diagnosis and hemodynamic assessment.
- Evaluation of interventional (embolization, surgery, radiosurgery) and emerging pharmacotherapy strategies.
Main Results:
- AVMs arise from germline and somatic genetic factors, perturbed signaling pathways, hemodynamic stress, and inflammation.
- Multimodal imaging, including DSA, MRI/MRA, CTA, and ultrasound, is crucial for diagnosis and risk assessment.
- Innovations in embolization devices and precision medicine offer improved treatment options, with ongoing development in genomic-imaging risk scores and targeted therapies.
Conclusions:
- Management of AVMs is individualized, multidisciplinary, and evolving with technological and therapeutic advancements.
- Precision medicine strategies targeting specific genetic pathways show promise for syndromic and mutation-driven AVMs.
- Future priorities include integrated genomic-imaging risk scores, genotype-informed therapies, and standardized long-term outcome measures focused on hemorrhage prevention and quality of life.
Related Concept Videos
Hemodialysis I: Introduction
Mechanism of Angiogenesis
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Anastomoses
Anastomoses can be formed at arterial, venous, and lymphatic vessels.
Arterial Anastomosis: These occur between arteries. They...
Venous Thrombosis III: Interprofessional Care

